Latest News

 Filter by Provider

CVS Health reported strong Q2 results with revenue and adjusted earnings surpassing estimates and raised its full-year 2025 guidance.

California Water Service Group (CWT) beat Q2 2025 earnings with $264.95M revenue and $0.71 EPS, but stock dipped slightly amid muted market reaction.

The S&P 500 is poised to reach a new record high this morning after a brief pullback on Tuesday and Wednesday.

Texas-based financial institution Cullen/Frost Bankers (NYSE:CFR) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 11.8% year on year to $567.8 million. Its GAAP profit of $2.39 per share was 3% above analysts’ consensus estimates.

You probably still have decades before you retire -- you can amass a lot of money in that time.

Economic consulting firm CRA International (NASDAQ:CRAI) announced better-than-expected revenue in Q2 CY2025, with sales up 9% year on year to $186.9 million. The company’s full-year revenue guidance of $737.5 million at the midpoint came in 1.8% above analysts’ estimates. Its non-GAAP profit of $1.88 per share was 2.4% above analysts’ consensus estimates.

Sanofi Q2 sales rose 10.1% at constant currency, led by Dupixent and ALTUVIIIO. EPS missed estimates; 2025 sales guidance was revised upward.

A raft of recent data shows households under increasing financial stress across all income levels.

Coinbase stock climbs ahead of earnings Thursday. Analysts raise price targets on momentum, crypto policy developments.

Shell Plc outperforms profit expectations in Q2 despite macro conditions and margin pressures. Adjusted earnings per share at $1.44. Revenue misses.

(BPT) - Children spend anywhere from 800 to 1,100 hours at school each year. For those with food allergies, that time comes with added risks. From cafeteria meals to classroom snacks, the risk of a food allergy exposure is an everyday concern.

The Shock Tariff Move: Trump's 50% tariff on copper products caused a shock wave, collapsing prices & causing losses for traders & ETFs.

Nebius is scheduled to report second-quarter earnings on Aug. 7.

Meta Platforms obliterated Wall Street's expectations in Q2, sending shares up over 10%. The tech stock continues to be one of the best AI plays in the market.

Resource management provider Itron (NASDAQ:ITRI) met Wall Street’s revenue expectations in Q2 CY2025, but sales were flat year on year at $606.8 million. On the other hand, next quarter’s revenue guidance of $577.5 million was less impressive, coming in 7.5% below analysts’ estimates. Its non-GAAP profit of $1.62 per share was 21.6% above analysts’ consensus estimates.

CEO Stéphane Bancel said in a note to employees on Thursday that the move is part of the company’s commitment to reduce annual operating expenses by about $1.5 billion by 2027.

The decision was widely expected and the US dollar has posted losses on Thursday against most of the major currencies after gaining strongly Wednesday to reach a new 2-month high.

This little-known biotech might still deliver strong returns.

Safety and specialty services provider APi (NYSE:APG) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 15% year on year to $1.99 billion. On top of that, next quarter’s revenue guidance ($2.01 billion at the midpoint) was surprisingly good and 4.6% above what analysts were expecting. Its non-GAAP profit of $0.39 per share was 4.2% above analysts’ consensus estimates.